Featured News Stories

Archive for 2015

Preora Diagnostics to Commercialize Cancer Pre-screening Tests


NanoCytomics LLC today announced the formation of Preora Diagnostics Inc., a privately held medical technology company that will bring low-cost cancer pre-screening tests to primary care physicians in the U.S. and other select markets. Click here to learn more.  Preora Launch Release . Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut maximus imperdiet leo, non mattis neque laoreet [Continue Reading]

Yearly Archives

Subscribe to News via Email

Enter your email address to subscribe to this news section and receive notifications of new posts by email.